TRACON PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
TRACON PHARMACEUTICALS INC. - More news...
TRACON PHARMACEUTICALS INC. - More news...
- Thinking about buying stock in BigBear.ai, MicroCloud Hologram, TRACON Pharmaceuticals, Spruce Biosciences, or Recursion Pharmaceuticals?
- Thinking about buying stock in Spruce Biosciences, Ensysce Biosciences, Immunitybio, Frontline, or TRACON Pharmaceuticals?
- Thinking about buying stock in BioNano Genomics, Ampio Pharmaceuticals, TRACON Pharmaceuticals, eMagin Corp, or Matinas BioPharma?
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 09-08-2020
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 09-01-2020
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 08-17-2020
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 01-23-2020
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 01-16-2020
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 12-20-2019
- TRACON Pharmaceuticals, Inc. - TCON Stock Chart Technical Analysis for 03-04-2019
- TRACON Pharmaceuticals, Inc. to Host Earnings Call
- TRACON Pharmaceuticals, Inc. to Host Earnings Call
- Investor Network: TRACON Pharmaceuticals, Inc. to Host Earnings Call
- Investor Network: TRACON Pharmaceuticals, Inc. to Host Earnings Call
- Tracon Pharmaceuticals
- TRACON Pharmaceuticals Receives Special Protocol Assessment (SPA) Agreement from FDA for Phase 3 Clinical Trial of TRC105 in Angiosarcoma
- TRACON Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
- TRACON Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- TRACON Pharmaceuticals to Host Key Opinion Leader Luncheon for Investors Focused on Angiosarcoma and Prostate Cancer on December 1 in New York City
- TRACON Pharmaceuticals Announces Proposed Public Offering of Common Stock
- TRACON Pharmaceuticals Presents Clinical and Preclinical Data from Models of NASH and Liver Fibrosis at the 2016 AASLD Annual Meeting
- TRACON Pharmaceuticals Announces Presentation of Updated Data from Phase 1b/2 Study of TRC105 and Votrient® in Patients with Angiosarcoma
- TRACON Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
- TRACON Pharmaceuticals to Present at Upcoming Investment Conferences
- TRACON Pharmaceuticals Announces Clinical Data Presentation at Upcoming Connective Tissue Oncology Society (CTOS) 2016 Annual Meeting
- TRACON to Report Third Quarter 2016 Company Highlights and Financial Results on November 8, 2016
- TRACON Pharmaceuticals Reports Granting of Inducement Awards
- TRACON Pharmaceuticals Presents Final Updated Phase 1b Results for TRC105 in Combination with Inlyta® in Renal Cell Carcinoma at the ESMO 2016 Congress
- TRACON Pharmaceuticals Announces Successful Meetings with FDA and EMA for TRC105 (carotuximab) in Angiosarcoma